news

In July 2019, the Boston University Access Observatory, an independently developed measurement framework that is separate from Access Accelerated, published its second annual report, “Establishing the Foundation for Shared Learning.” As the title suggests, the report underscores the efforts our member companies are making to demonstrate three of our cross-cutting principles in action: continuous learning, rigorous measurement and transparency.Read More

Access Accelerated in Action shares experiences from 19 member company NCD access programs implemented in collaboration with more than 50 cross-sector partners

GENEVA, SWITZERLAND – 20 May 2019 – Today, at a side event on the margins of the 72nd World Health Assembly, Access Accelerated, a global partnership of more than 20 biopharmaceutical companies, launched Access Accelerated in Action: Key Learnings in Program Design & Implementation. This resource is the first collective effort from Access Accelerated member companies to share insights from their NCD programs in low- and middle-income countries (LMICs). Access Accelerated in Action is an effort to enhance the impact of public-private partnerships to address the global NCD burden and strengthen health systems in support of Universal Health Coverage (UHC). Read More

Two global biopharmaceutical companies join effort to address the growing non-communicable disease burden in low- and middle-income countries

GENEVA, SWITZERLAND – Today, Ipsen and Servier, two global biopharmaceutical companies, joined Access Accelerated, an initiative aimed at advancing access to non-communicable disease (NCD) prevention, treatment and care in low- and middle income countries (LMICs). Together with partners from across the global biopharmaceutical sector, multilateral organizations and non-governmental organizations, Access Accelerated works toward a future where no one dies prematurely from treatable, preventable diseases.Read More


Access Accelerated returned to Kenya from 28 February to 1 March for the non-communicable diseases (NCDs) stakeholder meeting, “Redefining UHC – the Opportunity for NCDs,” co-hosted with the Ministry of Health and NCD Alliance Kenya in Naivasha. With representation from the Kenyan government across ministries and attendees that spanned civil society, representatives from 12 Access Accelerated member companies, people living with NCDs (PLWNCDs) and government officials from six African nations, the meeting provided a forum to reflect on progress made and recommit to increasing access to NCD treatment and care in the context of the country’s push toward Universal Health Coverage (UHC).
Read More


Cancer mortality rates in children show unacceptable inequalities between high and low- and middle-income countries. In the latter, late diagnosis, inadequate access to healthcare facilities, and treatment abandonment are the main hurdles for remission. For over 12 years, My Child Matters program has funded 58 cancer projects in more than 40 low- and middle-income countries, reaching so far over 85,000 children. The goal of this initiative, developed by the Fondation Sanofi Espoir, aims to bring equity so that all children with cancer will have the same chance to heal wherever they are in the world.Read More

This article presents the results of a pilot evaluation on diabetes knowledge and behavior of caregivers and school staff of providing education on diabetes in a school setting. The intervention is based on an educational package co-created by the International Diabetes Federation (IDF), the International Society for Pediatric and Adolescent Diabetes (ISPAD), local partners and Sanofi.
Read More